Concordance Between Point-of-Care Urine Ethyl Glucuronide Alcohol Tests and Self-Reported Alcohol Use in Persons with HIV in Uganda.


Journal

AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133

Informations de publication

Date de publication:
Aug 2022
Historique:
accepted: 20 01 2022
pubmed: 2 2 2022
medline: 7 7 2022
entrez: 1 2 2022
Statut: ppublish

Résumé

Screening and assessing alcohol use accurately to maximize positive treatment outcomes remain problematic in regions with high rates of alcohol use and HIV and TB infections. In this study, we examined the concordance between self-reported measures of alcohol use and point-of-care (POC) urine ethyl glucuronide (uEtG) test results among persons with HIV (PWH) in Uganda who reported drinking in the prior 3 months. For analyses, we used the screening data of a trial designed to examine the use of incentives to reduce alcohol consumption and increase medication adherence to examine the concordance between POC uEtG (300 ng/mL cutoff) and six measures of self-reported alcohol use. Of the 2136 participants who completed the alcohol screening, 1080 (50.6%) tested positive in the POC uEtG test, and 1756 (82.2%) self-reported using alcohol during the prior 72 h. Seventy-two percent of those who reported drinking during the prior 24 h had a uEtG positive test, with lower proportions testing uEtG positive when drinking occurred 24-48 h (64.7%) or 48-72 h (28.6%) prior to sample collection. In multivariate models, recency of drinking, number of drinks at last alcohol use, and Alcohol Use Disorders Identification Test - Consumption (AUDIT-C) score were associated with uEtG positivity. The highest area under the curve (AUC) for a uEtG positive test was for recency of drinking. Overall, we concluded that several measures of drinking were associated with POC uEtG positivity, with recency of drinking, particularly drinking within the past 24 h, being the strongest predictor of uEtG positivity.

Identifiants

pubmed: 35103888
doi: 10.1007/s10461-022-03597-6
pii: 10.1007/s10461-022-03597-6
pmc: PMC9256760
mid: NIHMS1782695
doi:

Substances chimiques

Glucuronates 0
ethyl glucuronide 17685-04-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2539-2547

Subventions

Organisme : NIAAA NIH HHS
ID : K01 AA026523
Pays : United States
Organisme : NIAAA NIH HHS
ID : K24 AA022586
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA026221
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA026223
Pays : United States

Informations de copyright

© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Références

Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
Curr HIV/AIDS Rep. 2010 Nov;7(4):226-33
pubmed: 20814765
Alcohol Clin Exp Res. 2019 Dec;43(12):2591-2598
pubmed: 31610017
Alcohol Alcohol. 2007 Jul-Aug;42(4):321-5
pubmed: 17533162
AIDS Behav. 2018 Jul;22(7):2334-2339
pubmed: 29336004
Ther Drug Monit. 2017 Aug;39(4):461-462
pubmed: 28520580
J Tuberc Res. 2016 Mar;4(1):18-22
pubmed: 27054144
PLoS One. 2014 Dec 01;9(12):e113152
pubmed: 25436894
Drug Alcohol Depend. 2014 Jan 1;134:136-143
pubmed: 24128380
Alcohol Clin Exp Res. 2007 Jul;31(7):1208-17
pubmed: 17451397
Addiction. 2016 Feb;111(2):272-9
pubmed: 26381193
AIDS Care. 2017 Nov;29(11):1442-1447
pubmed: 28278568
Biometrics. 2022 Mar;78(1):9-23
pubmed: 33021738
BMC Public Health. 2009 Dec 05;9:450
pubmed: 19961618
Int J Tuberc Lung Dis. 2015 Jan;19(1):111-9
pubmed: 25519800
Alcohol Clin Exp Res. 2016 Oct;40(10):2056-2072
pubmed: 27696523
BMJ Open. 2016 Apr 15;6(4):e009058
pubmed: 27084271
Alcohol Alcohol. 2009 Jan-Feb;44(1):55-61
pubmed: 18971292
Alcohol Clin Exp Res. 2014 Jul;38(7):2056-65
pubmed: 24773137
Drug Alcohol Depend. 2015 Dec 1;157:184-7
pubmed: 26475403
AIDS Behav. 2017 Nov;21(Suppl 2):126-143
pubmed: 28831609
J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):e63-4
pubmed: 23138732
Alcohol Clin Exp Res. 2015 May;39(5):905-10
pubmed: 25866234
Subst Abus. 2021;42(1):87-93
pubmed: 32040383

Auteurs

Karl C Alcover (KC)

Department of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd, Bethesda, MD, 20814, USA. karl.alcover@usuhs.edu.

Nneka I Emenyonu (NI)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Robin Fatch (R)

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Allen Kekibiina (A)

Mbarara University of Science and Technology, Mbarara, Uganda.

Kara Marson (K)

Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.

Gabriel Chamie (G)

Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.

Winnie R Muyindike (WR)

Department of Internal Medicine, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.

Brian Beesiga (B)

Infectious Diseases Research Collaboration, Kampala, Uganda.

Moses R Kamya (MR)

Department of Medicine, Makerere University, Kampala, Uganda.

Sara Lodi (S)

Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.

Jeremy C Kane (JC)

Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.

Judith A Hahn (JA)

Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.

Michael G McDonell (MG)

Behavioral Health Innovations, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH